1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Lung Inflammation: new trials by email Literature Review of Lung Inflammation trials Research Report on Lung Inflammation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treat COVID-19 Patients With Regadenoson Regadenoson, Placebo Control - COVID-19, Lung Inflammation | Phase 1 / Phase 2 | Completed | University of Maryland, Baltimore | 5 | 2021-05-06 | 2025-03-20 |
Coronaviridae Infections (1) · Coronavirus Infections (1) · Infections (1) · Lung Diseases (1) · Nidovirales Infections (1) · Pneumonia, Viral (1) · RNA Virus Infections (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1) · Virus Diseases (1)
Sodium Chloride (1) · regadenoson (1)
University of Maryland, Baltimore (1)
United States (1)